Literature DB >> 25589918

Dual leucine zipper kinase inhibitors: potential treatments for neurodegenerative diseases.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2014        PMID： 25589918      PMCID： PMC4291697          DOI： 10.1021/ml500347s

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

1.  DLK: the "preconditioning" signal for axon regeneration?

Authors:  Paola Nix; Michael Bastiani
Journal:  Neuron       Date:  2012-06-21       Impact factor: 17.173

Review 2.  Dual leucine zipper kinase as a therapeutic target for neurodegenerative conditions.

Authors:  Dana Ferraris; Zhiyong Yang; Derek Welsbie
Journal:  Future Med Chem       Date:  2013-10       Impact factor: 3.808

Review 3.  The DLK signalling pathway--a double-edged sword in neural development and regeneration.

Authors:  Andrea Tedeschi; Frank Bradke
Journal:  EMBO Rep       Date:  2013-05-17       Impact factor: 8.807
  3 in total
  1 in total

Review 1.  Discovery of novel inhibitors for the treatment of glaucoma.

Authors:  Kishore Cholkar; Hoang M Trinh; Dhananjay Pal; Ashim K Mitra
Journal:  Expert Opin Drug Discov       Date:  2015-01-09       Impact factor: 6.098
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.